-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on TransMedics Group, Lowers Price Target to $118

Benzinga·04/06/2026 17:39:03
Listen to the news
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $170 to $118.